Thermo Fisher Scientific on Pace for Largest Percent Increase Since July 2023 — Data Talk
Thermo Fisher Scientific Inc. (TMO) is currently at $572.66, up $24.28 or 4.43%
--Would be highest close since April 11, 2024, when it closed at $574.57
--On pace for largest percent increase since July 21, 2023, when it rose 4.44%
--Currently up three consecutive days; up 5.75% over this period
--Best three day stretch since the three days ending Dec. 13, 2023, when it rose 5.87%
--Down 1.47% month-to-date; on pace for worst month since Oct. 2023, when it fell 12.13%
--Up 7.89% year-to-date
--Down 14.17% from its all-time closing high of $667.24 on Dec. 31, 2021
--Up 4.43% from 52 weeks ago (April 25, 2023), when it closed at $548.38
--Down 4.47% from its 52-week closing high of $599.43 on March 11, 2024
--Up 32.74% from its 52-week closing low of $431.41 on Oct. 27, 2023
--Traded as high as $572.89; highest intraday level since April 12, 2024, when it hit $573.38
--Up 4.47% at today's intraday high; largest intraday percent increase since Nov. 21, 2023, when it rose as much as 4.54%
--Ninth best performer in the S&P 500 today
All data as of 10:36:11 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 23, 2024 10:53 ET (14:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks